← Back

$ Value

Shares

13,458

Price

Filed

Nov 12

Insider

Name

Horvath Mark W.

Title

President, Breast & Skeletal

CIK

0002052858

Roles

Officer

Transaction Details

Transaction Date

2025-11-10

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,139

Footnotes

Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 10, 2025. | Restricted stock units are settled in shares of common stock on a one-for-one basis. | Includes 4,605 performance stock units/restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.

Filing Info

Accession No.

0000859737-25-000050

Form Type

4

Issuer CIK

0000859737

Horvath Mark W.'s History

Date Ticker Type Value
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX A
2026-04-07 HOLX D
2026-02-10 HOLX F $8K

Other Insiders at HOLX (90d)

Insider Bought Sold Last
MACMILLAN STEPHEN P
Chairman, President and CEO
2026-04-07
Madaus Martin D 2026-04-07
Oberton Karleen Marie
Chief Financial Officer
2026-04-07
Dockendorff Charles J 2026-04-07
Wendell Amy McBride 2026-04-07
Stewart Stacey D. 2026-04-07
HANTSON LUDWIG 2026-04-07
Stamoulis Christiana 2026-04-07
COHN BENJAMIN JORDAN
Principal Accounting Officer
2026-04-07
McMillan Wayde D. 2026-04-07
Verstreken Jan
Group President, International
2026-04-07
Mitchell Essex D
Chief Operating Officer
2026-04-07
Schneiders Jennifer M
President, Diag. Solutions
2026-04-07
Mohtashami Nanaz 2026-04-07
Schnittker Brandon
President, GYN Surgical
2026-04-07
De Walt Diana
SVP, Human Resources
2026-04-07
Horvath Mark W.
President, Breast & Skeletal
2026-04-07
Liddy Anne M.
General Counsel
2026-04-07